1. Home
  2. Live Updates
  3. Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus' Post Grant Review -March 27, 2024 at 08:42 am EDT : vimarsana.com

Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus' Post Grant Review -March 27, 2024 at 08:42 am EDT : vimarsana.com

Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus' Post Grant Review -March 27, 2024 at 08:42 am EDT

Marinus Pharmaceuticals, Inc. , a pharmaceutical company dedicated to developing and commercializing innovative therapeutics to treat seizure disorders, today affirmed its commitment to defending its...

Related Keywords

Scott Braunstein , Exchange Commission , Nasdaq , Marinus Pharmaceuticals , Patent Office , Ovid Therapeutics Inc , Marinus Pharmaceuticals Inc , Inter Partes Review , Ovid Therapeutics , Marinu Phase , Patent Trial , Appeal Board , Private Securities Litigation Reform Act , Markets ,

© 2024 Vimarsana